← Leaderboards
Martin Borch Jensen
Gordian Biotechnology, Inc.
$1,075,487
Attributed
$1,075,487
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $811.4K · FY2017–23$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,075,487 · 2
By mechanism
R44$811,373 · 1
K99$264,114 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Cost”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Scott Topper · Broad Institute, Inc.$77,958,806
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Mark Marino · Venturewell$48,913,644
- John Damon Chodera · Sloan-Kettering Inst Can Research$48,367,817
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,527,040
Research focus
CostAlzheimer&AposCellsGenetic TranscriptionResponseSeveritiesImmuneAmyloid Beta-ProteinAntibodiesAge RelatedCell TypeAntimicrobial PeptideBacteriaBar CodesAntibioticsAnimal TestingAlgorithmsCareer DevelopmentCause Of DeathCell ModelCell PhysiologyBrainAmyloid PeptideBlood
Grant awards (3)
In Vitro Toxicity Testing at Massive Scale in Diverse Primary Human Cells$811,373
R44 · FY2023 · ES · contact PI
Modulating Alzheimer's Disease progression by preserving intestinal health.$132,057
K99 · FY2018 · AG · contact PI
Modulating Alzheimer's Disease progression by preserving intestinal health.$132,057
K99 · FY2017 · AG · contact PI